Excretion Balance of 14c-radiolabeled BIRB 796 BS in Normal Male Subjects
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to characterize the pharmacokinetics of 14C-radiolabeled BIRB 796 BS and its
metabolites including excretion and mass balance of parent compound and radioactivity; to
isolate, identify and quantify major radiolabeled metabolites of BIRB 796 in plasma, urine
and feces